Shattuck Labs, Inc. Common Stock (STTK) Stock
NASDAQ · STTK
Key stats
- Market cap
- $514.30M
- Price / Earnings ratio
- -7.3x
- EPS (TTM)
- -$0.47
- Volume
- Loading
- 52-week high
- $8.33
- 52-week low
- $1.72
Source: third-party data provider, as of November 13, 2026
Compare with STTK
Recent news

The Motley Fool
What Shattuck Labs Stock Topped the Market on Monday
STTKAugust 24, 2026
The Motley Fool
What Shattuck Labs Stock Topped the Market on Monday
STTK

Zacks Investment Research
Shattuck Labs, Inc. (STTK) is a Great Momentum Stock: Should You Buy?
STTKAugust 20, 2026
Zacks Investment Research
Shattuck Labs, Inc. (STTK) is a Great Momentum Stock: Should You Buy?
STTK

Zacks Investment Research
Wall Street Analysts Believe Shattuck Labs (STTK) Could Rally 85.31%: Here's is How to Trade
STTKAugust 13, 2026
Zacks Investment Research
Wall Street Analysts Believe Shattuck Labs (STTK) Could Rally 85.31%: Here's is How to Trade
STTK

The Motley Fool
Why Shattuck Labs Stock Flew Nearly 5% Higher on Friday
STTKJuly 24, 2026
The Motley Fool
Why Shattuck Labs Stock Flew Nearly 5% Higher on Friday
STTK
Technical indicators
- RSI 14
- 42.65
- MACD 12/26/9
- -0.31
- EMA 9 of MACD
- -0.28
- MACD histogram
- -0.03
- SMA 50
- $5.88
- Price below SMA 50
- EMA 50
- $5.80
- Price below EMA 50
- SMA 200
- $6.06
- Price below SMA 200
- EMA 200
- $5.56
- Price below EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst ratings
Analyst consensus: Buy
Based on 4 analyst ratings
Strong Sell0
Sell0
Hold0
Buy3
Strong Buy1
Third-party analyst opinion, not a recommendation from Gotrade.
Financials
Performance
Revenue
Net income
Net margin %
2021
2022
2023
2024
2025
36M24M12M0
Debt & Balance Sheet
Total assets
Total liabilities
2021
2022
2023
2024
2025
358M236M118M0
Revenue to Profit
2025$1.0M
Revenue$0.0
Cost of revenue$1.0M
Gross profit$0.0
Operating expenses$-48.8M
Net incomeEarnings
No data available
Source: third-party data provider
Latest news

The Motley Fool
What Shattuck Labs Stock Topped the Market on Monday
STTKAugust 24, 2026
The Motley Fool
What Shattuck Labs Stock Topped the Market on Monday
STTK

Zacks Investment Research
Shattuck Labs, Inc. (STTK) is a Great Momentum Stock: Should You Buy?
STTKAugust 20, 2026
Zacks Investment Research
Shattuck Labs, Inc. (STTK) is a Great Momentum Stock: Should You Buy?
STTK

Zacks Investment Research
Wall Street Analysts Believe Shattuck Labs (STTK) Could Rally 85.31%: Here's is How to Trade
STTKAugust 13, 2026
Zacks Investment Research
Wall Street Analysts Believe Shattuck Labs (STTK) Could Rally 85.31%: Here's is How to Trade
STTK

The Motley Fool
Why Shattuck Labs Stock Flew Nearly 5% Higher on Friday
STTKJuly 24, 2026
The Motley Fool
Why Shattuck Labs Stock Flew Nearly 5% Higher on Friday
STTK

The Motley Fool
Why Shattuck Labs Stock Soared More Than 53% Higher This Week
STTKMarch 6, 2026
The Motley Fool
Why Shattuck Labs Stock Soared More Than 53% Higher This Week
STTK

The Motley Fool
Why Shattuck Labs Stock Soared in December
STTKJanuary 6, 2026
The Motley Fool
Why Shattuck Labs Stock Soared in December
STTK
About Shattuck Labs, Inc. Common Stock
No description available.
SectorHealthcare
IndustryBiotechnology
Employees40
CEODr. Taylor H. Schreiber M.D., Ph.D.
IPO DateOct 9, 2020
HeadquartersAustin, TX
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Dr. Taylor H. Schreiber M.D., Ph.D. | Co-Founder, CEO & Director | 1980 |
| Mr. Andrew R. Neill M.B.A. | Chief Financial Officer | 1986 |
| Dr. Arunthathy Nirmalini Pandite M.B.A., M.D. | Chief Medical Officer | 1959 |
| Mr. Brad Huckabee | Vice President of Accounting & SEC reporting | — |
| Dr. Abhinav A. Shukla Ph.D. | Chief Technical Officer | 1973 |
| Mr. Suresh de Silva Ph.D. | Chief Scientific Officer | — |
| Dr. Stephen Stout J.D., Ph.D. | General Counsel, Corporate Secretary and Chief Ethics & Compliance Officer | 1975 |
| Ms. Casi DeYoung | Chief Business Officer | 1971 |
| Dr. Thomas Lampkin Pharm.D. | Senior Vice President of Regulatory Affairs | — |
| Ms. Kelli Collin M.B.A., M.S. | Senior Vice President of Quality | — |
Fundamentals
Valuation
Price-to-sales ratio493.90
Price-to-book value2.55
Profitability
Return on Equity-47.00%
Return on Assets-44.00%
EBITDA$-63.73M
Trading
Average volume984,549
Source: third-party data provider, as of November 13, 2026
Technical indicators
- RSI 14
- 42.65
- MACD 12/26/9
- -0.31
- EMA 9 of MACD
- -0.28
- MACD histogram
- -0.03
- SMA 50
- $5.88
- Price below SMA 50
- EMA 50
- $5.80
- Price below EMA 50
- SMA 200
- $6.06
- Price below SMA 200
- EMA 200
- $5.56
- Price below EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst views
4 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
Analyst consensus:Buy
100% Buy
0% Hold
0% Sell
Analyst price target
- Low
- $14.00
- Average
- $17.00
- High
- $19.00
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | -32.1 | +1.2 | ||||||||||
| 2022 | -22.3 | -28.5 | -15.0 | -4.0 | -27.4 | +41.5 | -13.4 | -7.1 | -16.4 | -1.9 | -18.1 | -3.4 |
| 2023 | +66.8 | +16.5 | -35.4 | +0.0 | -10.1 | +8.7 | -19.3 | -6.1 | -32.4 | +8.0 | +22.5 | +263.8 |
| 2024 | +24.9 | -8.1 | -7.4 | +17.9 | -32.0 | -47.3 | -0.3 | -4.8 | +1.7 | -34.4 | -12.0 | +11.0 |
| 2025 | -4.1 | +2.3 | -22.1 | +16.5 | -6.5 | -24.8 | -7.3 | +34.2 | +136.6 | -19.3 | +5.5 | +51.5 |
| 2026 | +4.3 | +1.8 | +60.7 | +14.4 | -14.9 | +22.8 | +8.6 | -3.8 | -0.7 | -18.7 | -5.1 |
Compare stocks
Market cap
$514.30M
-
-
-
Price / Earnings ratio
-7.30
-
-
-
Price / Sales ratio
493.90
-
-
-
Dividend yield
0.00%
-
-
-
Average volume
984,549
-
-
-
Earnings per share
$-0.47
-
-
-



